​NanoMicro at CPHI KOREA 2026: Connecting with Korea’s Growing Biopharmaceutical Ecosystem

August 28, 2026 | Seoul, Korea

From August 25 to 27, 2026, NanoMicro participated in CPHI KOREA 2026 at COEX Seoul, engaging with pharmaceutical, biopharmaceutical, CDMO and life science professionals from Korea and international markets.

The 2026 edition brought together 478 companies from 22 countries, with more than 12,000 buyers and visitors expected from 90 countries. International pre-registered visitors accounted for almost 20%, the highest proportion in the past four years.

Connecting with Korea’s Biopharmaceutical Industry

Korea has developed into an important pharmaceutical and biopharmaceutical hub in Asia, with strong capabilities in biologics, biosimilars, CDMO services and global pharmaceutical manufacturing.

The exhibition provided NanoMicro with an opportunity to engage directly with local customers and partners and gain a deeper understanding of the requirements of Korea’s increasingly sophisticated pharmaceutical market.

For chromatography and purification technologies, this represents an important environment where product performance, consistency, quality and technical support all play an important role in customer evaluation.

Supporting Advanced Separation and Purification

At CPHI KOREA 2026, NanoMicro showcased chromatography media covering affinity, ion exchange, size exclusion, hydrophobic interaction and reversed-phase chromatography.

The portfolio supports purification challenges across proteins, peptides, oligonucleotides and other complex biomolecules.

Through its broader ecosystem, NanoMicro continues to develop solutions spanning separation, purification and analysis, supporting customers from research and process development to scale-up and manufacturing.

Building Local Partnerships

During the exhibition, NanoMicro engaged with pharmaceutical companies, biotechnology companies, CDMOs and potential local partners.

These discussions reinforced the importance of combining strong product performance with application expertise, quality assurance and responsive local support.

For NanoMicro, Korea represents an important market for building long-term customer relationships and developing practical application experience within an internationally connected pharmaceutical ecosystem.

Looking Ahead

CPHI KOREA 2026 represents another step in NanoMicro’s international expansion across key Asian pharmaceutical markets.

NanoMicro will continue to strengthen its presence in Korea through customer engagement, application development and local partnerships, while bringing high-performance separation and purification technologies to pharmaceutical and biopharmaceutical customers worldwide.

From separation to purification, NanoMicro is committed to building long-term partnerships and supporting the global pharmaceutical industry with reliable technologies and application-focused solutions.